Differentiating TYK2 inhibitors with real-world evidence in psoriasis

Read more

How HealthVerity Audiences delivered 26.9x targeting precision for a rare kidney disease campaign

Read more

Standardized cost measures for real-world evidence

Read more

Beyond Reach: How Health Marketers Evaluate Data Partners

Read more

Does your data link?

Read more

Symphony Health Client Webinar

Read more

Reducing targeting noise by supplementing claims with oncology labs

Read more

Can We Trust Agentic AI?

Read more

Cost data in real-world evidence

Read more

GLP-1 Marketing: How Pharma Marketers Can Reach the Right Patients

Read more

What Pharma Marketing Can Learn from Defense-Grade Data Strategy

Read more

Accurately targeting chronic liver disease patients for specialty therapy

Read more

Accurately reaching patients with rare hematologic disease

Read more

GLP-1s

Read more

Accelerating early RWE exploration without increasing analytic burden

Read more

Validating HealthVerity eXOs

Read more

The RWE Backlog Problem

Read more

Founding Philly Ep. 49 – Andrew Goldberg

Read more

AI and RWD – Where are the opportunities in life sciences?

Read more

Cardiometabolic research in the GLP-1 era

Read more

The Missing Pieces: How Rare Disease Diagnoses Come Together

Read more

Disrupting Healthcare Audiences

Read more

Uncover what keeps GLP-1 patients on therapy, and what doesn’t

Read more

The RWD/RWE Inflection Point in 2026

Read more

Guide to comprehensive patient journeys

Read more

Expert Insights on Re-Identification Risk

Read more

Closing the evidence gap before year-end

Read more

Accelerate your real-world evidence with agentic AI

Read more

Mitigating the Risks of Low-Quality Data for Commercial Pharma

Read more

Don’t just follow the journey – Take notes

Read more

The Marketplace model is winning. Here’s why.

Read more

taXonomy 2025: Solving for payer coverage scarcity

Read more

Zombie Data vs. Verified Data

Read more

Guide to claiming better outreach

Read more

Revealing the top data trends for 2025

Read more

Introducing taXOnomy: Claim better outreach

Read more

Guide to claiming better outcomes

Read more

Early access to next-generation patient and HCP targeting and activation

Read more

Introducing taXonomy: Claim better outcomes

Read more

The biomarker advantage

Read more

Mastering precision, not indecision

Read more

Demonstrating the safety and effectiveness of an anti-seizure medication with real-world data

Read more

Pathways to success in AI

Read more

Revealing the top data trends for 2024

Read more

Validating audience quality to improve campaign outcomes

Read more

Media attribution for real-time campaign optimization

Read more

Break out of the black box

Read more

Synchronizing the Science℠

Read more

The Token is Broken: Part II

Read more

The Token is Broken: Part I

Read more

Data-Driven Trigger Programs that Accelerate Product Launch and Uptake

Read more

Industry Insights: The secret to expediting drug approval

Read more

Teaming up to fight diabetes

Read more

Applying public health lessons to life sciences, clinical trials and registries

Read more

Future-proof your approach to healthcare marketing optimization

Read more

Discover powerful insights to patient cohorts in minutes with ready-to-query lab data

Read more

Maternal Outcomes Masterset (MOM): Part I

Read more

Maternal Outcomes Masterset (MOM): Part II

Read more

The holistic patient journey: Fusing RWD with person-generated health data

Read more

Unlocking patient engagement in a digital-first future for life sciences

Read more

The role of RWE: Longitudinal patient insights bridging clinical and real-word data

Read more

From First Impressions to Patient Outcomes

Read more

RWE and real-time insights

Read more